Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD

Summary

The purpose of this study is to evaluate the safety and efficacy of autologous Platelet Rich Plasma (PRP) and Platelet Poor Plasma (PPP) eye drops four times a day in the treatment of ocular graft versus host disease (O-GVHD). In addition to their current medication (except autologous serum drops), patients will receive PRP and PPP drops.

Timeline

Start

2016-12

Primary completion

2018-09

Completion

2018-09

Outcome

Outcome not reported

Stopped (Enrollment): “Study did not enroll participants is being withdrawn from the system.”

Drugs

Indications